Discover the power of GLP-1 therapies like Ozempic, Wegovy, and Mounjaro. A scientifically proven, non-surgical path to significant weight loss under expert medical supervision.
You've likely heard names like Ozempic, Wegovy, or Mounjaro. These are not "magic diet pills" but advanced medications known as GLP-1 agonists.
How they work in simple terms: Your body naturally produces a hormone called GLP-1 after you eat, which tells your brain "I'm full." In many people struggling with weight, this signal is weak. These injectables mimic that hormone at a higher level, quieting the "food noise" in your brain and slowing down digestion.

Full blood panel, thyroid check, and history review.
Selecting the right molecule starting at a low dose.
Gradually increasing dosage over weeks to minimize side effects.
Monthly monitoring to sustain weight loss and adjust as needed.
While highly effective, these medications are potent and require medical supervision. Most side effects are gastrointestinal and improve over time.
We start with a low dose and increase slowly ("titration") to help your body adapt comfortably.
Understanding where medical therapy fits in the spectrum of obesity treatment.
| Feature | Medical Injectables | Bariatric Surgery | Diet & Lifestyle |
|---|---|---|---|
| Expected Weight Loss | 15-22% | 30-40% | 5-10% |
| Invasiveness | Non-Invasive (Needle) | Minimally Invasive | None |
| Reversibility | Fully Reversible | Permanent / Semi-Perm | Reversible |
| Maintenance Required | Ongoing Medication | Lifestyle + Vitamins | High Willpower |
* Results vary by individual. Surgery is generally recommended for BMI >35/40, while injectables are ideal for BMI 27-35 or pre-surgical optimization.
Empowering you with knowledge. Watch Dr. Arush Sabharwal explain complex medical topics in simple terms.
Learn about Body Mass Index (BMI) and how it relates to your overall health and weight management goals
Stop guessing and start treating. Book a comprehensive evaluation with Dr. Arush Sabharwal to see if you qualify for GLP-1 therapy.